BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1321894)

  • 1. Outcomes in low-risk babies treated with half-dose chemotherapy according to the Third National Wilms' Tumor Study.
    Corn BW; Goldwein JW; Evans I; D'Angio GJ
    J Clin Oncol; 1992 Aug; 10(8):1305-9. PubMed ID: 1321894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor: a report from the National Wilms' Tumor Study Group.
    Green DM; Breslow NE; Beckwith JB; Finklestein JZ; Grundy PE; Thomas PR; Kim T; Shochat SJ; Haase GM; Ritchey ML; Kelalis PP; D'Angio GJ
    J Clin Oncol; 1998 Jan; 16(1):237-45. PubMed ID: 9440748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxorubicin for favorable histology, Stage II-III Wilms tumor: results from the National Wilms Tumor Studies.
    Breslow NE; Ou SS; Beckwith JB; Haase GM; Kalapurakal JA; Ritchey ML; Shamberger RC; Thomas PR; D'Angio GJ; Green DM
    Cancer; 2004 Sep; 101(5):1072-80. PubMed ID: 15329918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study.
    Tournade MF; Com-Nougué C; de Kraker J; Ludwig R; Rey A; Burgers JM; Sandstedt B; Godzinski J; Carli M; Potter R; Zucker JM;
    J Clin Oncol; 2001 Jan; 19(2):488-500. PubMed ID: 11208843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of duration of treatment on treatment outcome and cost of treatment for Wilms' tumor: a report from the National Wilms' Tumor Study Group.
    Green DM; Breslow NE; Beckwith JB; Finklestein JZ; Grundy P; Thomas PR; Kim T; Shochat S; Haase G; Ritchey M; Kelalis P; D'Angio GJ
    J Clin Oncol; 1998 Dec; 16(12):3744-51. PubMed ID: 9850017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of the United Kingdom Children's Cancer Study Group first Wilms' Tumor Study.
    Pritchard J; Imeson J; Barnes J; Cotterill S; Gough D; Marsden HB; Morris-Jones P; Pearson D
    J Clin Oncol; 1995 Jan; 13(1):124-33. PubMed ID: 7799012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment outcomes in patients less than 2 years of age with small, stage I, favorable-histology Wilms' tumors: a report from the National Wilms' Tumor Study.
    Green DM; Breslow NE; Beckwith JB; Takashima J; Kelalis P; D'Angio GJ
    J Clin Oncol; 1993 Jan; 11(1):91-5. PubMed ID: 8380295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy-related toxicity in infants treated according to the Second National Wilms' Tumor Study.
    Morgan E; Baum E; Breslow N; Takashima J; D'Angio G
    J Clin Oncol; 1988 Jan; 6(1):51-5. PubMed ID: 2826715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of children with stages II to IV anaplastic Wilms' tumor: a report from the National Wilms' Tumor Study Group.
    Green DM; Beckwith JB; Breslow NE; Faria P; Moksness J; Finklestein JZ; Grundy P; Thomas PR; Kim T; Shochat S
    J Clin Oncol; 1994 Oct; 12(10):2126-31. PubMed ID: 7931483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.
    Dome JS; Cotton CA; Perlman EJ; Breslow NE; Kalapurakal JA; Ritchey ML; Grundy PE; Malogolowkin M; Beckwith JB; Shamberger RC; Haase GM; Coppes MJ; Coccia P; Kletzel M; Weetman RM; Donaldson M; Macklis RM; Green DM
    J Clin Oncol; 2006 May; 24(15):2352-8. PubMed ID: 16710034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of children with stage IV favorable histology Wilms tumor: a report from the National Wilms Tumor Study Group.
    Green DM; Breslow NE; Evans I; Moksness J; D'Angio GJ
    Med Pediatr Oncol; 1996 Mar; 26(3):147-52. PubMed ID: 8544795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
    Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
    Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Wilms' tumour of unfavorable histology--results of treatment with the SIOP 93-01 protocol at the Gdańsk centre. Preliminary report].
    Stefanowicz J; Sierota D; Balcerska A; Stoba C
    Med Wieku Rozwoj; 2004; 8(2 Pt 1):197-200. PubMed ID: 15738594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of radiation therapy delay on abdominal tumor recurrence in patients with favorable histology Wilms' tumor treated on NWTS-3 and NWTS-4: a report from the National Wilms' Tumor Study Group.
    Kalapurakal JA; Li SM; Breslow NE; Beckwith JB; Macklis R; Thomas PR; D'Angio GJ; Kim T; de Lorimier A; Kelalis P; Shochat S; Ritchey M; Haase G; Hrabovsky E; Otherson HB; Grundy P; Green DM;
    Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):495-9. PubMed ID: 12957262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapse of unilateral favorable histology Wilms' tumor: significant clinicopathological factors.
    Aoba T; Urushihara N; Fukumoto K; Furuta S; Fukuzawa H; Mitsunaga M; Watanabe K; Yamoto M; Miyake H; Koyama M; Iwabuchi H; Koike J; Tatsunami S; Wakisaka M; Kitagawa H
    J Pediatr Surg; 2012 Dec; 47(12):2210-5. PubMed ID: 23217878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of duration of treatment on treatment outcome for patients with clear-cell sarcoma of the kidney: a report from the National Wilms' Tumor Study Group.
    Seibel NL; Li S; Breslow NE; Beckwith JB; Green DM; Haase GM; Ritchey ML; Thomas PR; Grundy PE; Finklestein JZ; Kim T; Shochat SJ; Kelalis PP; D'Angio GJ
    J Clin Oncol; 2004 Feb; 22(3):468-73. PubMed ID: 14752069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wilms' tumor: diagnosis and treatment in the 1990s.
    Shochat SJ
    Semin Pediatr Surg; 1993 Feb; 2(1):59-68. PubMed ID: 8062023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced therapy for Wilms' tumor: analysis of treatment results from a single institution.
    Wilimas JA; Douglass EC; Lewis S; Fairclough D; Fullen G; Parham D; Kumar AP; Hustu HO; Fleming I
    J Clin Oncol; 1988 Oct; 6(10):1630-5. PubMed ID: 2845012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic significance of blastemal predominant histology in initially resected Wilms' tumors: a report from the Study Group for Pediatric Solid Tumors in the Kyushu Area, Japan.
    Kinoshita Y; Suminoe A; Inada H; Yagi M; Yanai F; Zaizen Y; Nishi M; Inomata Y; Kawakami K; Matsufuji H; Suenobu S; Handa N; Kohashi K; Oda Y; Hara T; Taguchi T
    J Pediatr Surg; 2012 Dec; 47(12):2205-9. PubMed ID: 23217877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Renal neoplasms in children].
    Sawicz-Birkowska K; Czernik J; Bagłaj M; Czauderna P; Kantorowicz-Szymik S; Poznański WA; Mańkowski P; Madziara W; Prokurat A; Osemlak J
    Przegl Lek; 2004; 61 Suppl 2():20-3. PubMed ID: 15686041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.